Injectable
SemaglutideplusGlycine
An advanced GLP-1 receptor agonist formulation designed for effective weight management and metabolic optimization.
- Once-weekly subcutaneous injection
- Regulates appetite and blood sugar via GLP-1 receptor agonism
- Glycine adjunct supports muscle recovery and cellular repair
- Five vial sizes from 2.5 mg / 1 mL to 12.5 mg / 5 mL
About the ingredient
Semaglutide + Glycine
Semaglutide is a long-acting GLP-1 analog that suppresses appetite and slows gastric emptying. Glycine is a non-essential amino acid that supports muscle protein synthesis and metabolic recovery.
Semaglutide + Glycine is an advanced GLP-1 receptor agonist formulation designed for effective weight management and metabolic optimization. This injectable combines Semaglutide, a proven GLP-1 analog that regulates blood sugar and reduces appetite, with Glycine, an amino acid that supports muscle recovery, cellular repair, and improved metabolic health.
Administered once weekly via subcutaneous injection, this dual formulation promotes consistent weight loss, enhances insulin sensitivity, and supports overall wellness. The addition of Glycine complements Semaglutide's mechanism of action by aiding in metabolic recovery and promoting better long-term results.
GLP-1 receptor agonism
Semaglutide mimics endogenous GLP-1, stimulating insulin release and signaling satiety to the hypothalamus — reducing appetite and food intake.
Glycine adjunct
Glycine is the simplest amino acid and a key building block for muscle protein, collagen, and neurotransmitter synthesis. Co-administration is intended to support recovery during caloric restriction.
Once-weekly cadence
Semaglutide's long half-life enables once-weekly dosing, improving adherence compared to daily or twice-daily medications.
How to take
A consistent routine matters.
Follow the specific directions from your healthcare provider. These steps are a general reference for injectable administration.
- 1
Inspect the vial — solution should be clear and free of particles before each use.
- 2
Clean the vial stopper with a fresh alcohol swab and let it air-dry.
- 3
Draw the prescribed dose using an insulin syringe; tap out any air bubbles.
- 4
Inject subcutaneously into the abdomen, thigh, or upper arm, rotating sites each dose.
- 5
Discard the used syringe immediately in an FDA-cleared sharps container.
Product Details
Available formulations
| Vial | Vial Total mg | Concentration | mL |
|---|---|---|---|
 | 2.5 mg | 2.5 mg / 20 mg/mL | 1 mL |
 | 5 mg | 2.5 mg / 20 mg/mL | 2 mL |
 | 7.5 mg | 2.5 mg / 20 mg/mL | 3 mL |
 | 10 mg | 5 mg / 20 mg/mL | 2 mL |
 | 12.5 mg | 2.5 mg / 20 mg/mL | 5 mL |
Typical dosage & titration
Recommended titration schedule
Reference schedule only — your provider may adjust the timing or dose based on your individual response and lab work.
| Weeks | Units | MG | ML | SIG / Directions |
|---|---|---|---|---|
| 1–4 | 10 | 0.25 mg | 0.1 mL | Inject 10 units (0.25 mg) subcutaneously once weekly. |
| 5–8 | 20 | 0.50 mg | 0.2 mL | Inject 20 units (0.5 mg) subcutaneously once weekly. |
| 9–12 | 40 | 1 mg | 0.4 mL | Inject 40 units (1 mg) subcutaneously once weekly. |
| 13–16 | 60 | 1.5 mg | 0.6 mL | Inject 60 units (1.5 mg) subcutaneously once weekly. |
| 17–20 | 80 | 2 mg | 0.8 mL | Inject 80 units (2 mg) subcutaneously once weekly. |
| 21+ | 100 | 2.5 mg | 1.0 mL | Inject 100 units (2.5 mg) subcutaneously once weekly. |
FAQ
Frequently asked questions
Provider workflow
Ready to prescribe Semaglutide?
Submit a prescription through the Logos RX provider portal, or reach out to our pharmacy team for formulary, dosing, or patient-onboarding questions.
Semaglutide
Provider onboarding portal